Simultaneously, Akt-mediated inactivation of GSK3β promotes β-catenin-driven survival programs, while mTORC1 suppresses autophagy, a process that may either protect glioma cells or shift toward a death-promoting role depending on context [17,18,19,20,21,22,23]. The gene discussed is AKT1; the disease is central nervous system cancer.